Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

2.

Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Jicha GA.

J Mol Neurosci. 2011 Nov;45(3):713-23. doi: 10.1007/s12031-011-9558-7. Epub 2011 Jun 7. Review.

PMID:
21647712
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.

Seltman RE, Matthews BR.

CNS Drugs. 2012 Oct 1;26(10):841-70. doi: 10.2165/11640070-000000000-00000. Review.

PMID:
22950490
[PubMed - indexed for MEDLINE]
4.

[Frontotemporal dementia: a review].

Chauvire V, Even C, Thuile J, Rouillon F, Guelfi JD.

Encephale. 2007 Dec;33(6):933-40. doi: 10.1016/j.encep.2006.12.001. Epub 2007 Sep 6. Review. French.

PMID:
18789785
[PubMed - indexed for MEDLINE]
5.

Frontotemporal dementia: recommendations for therapeutic studies, designs, and approaches.

Freedman M.

Can J Neurol Sci. 2007 Mar;34 Suppl 1:S118-24. Review.

PMID:
17469694
[PubMed - indexed for MEDLINE]
6.

A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia.

Huey ED, Putnam KT, Grafman J.

Neurology. 2006 Jan 10;66(1):17-22. Review.

PMID:
16401839
[PubMed - indexed for MEDLINE]
7.

Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies.

Boxer AL, Boeve BF.

Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):S79-87. Review.

PMID:
18090429
[PubMed - indexed for MEDLINE]
8.

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).

Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Jackson G, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian ZS, Sutherland M, Abushakra S, Lewcock J, Farese R, Kenet RO, Laferla F, Perrin S, Whitaker S, Honig L, Mesulam MM, Boeve B, Grossman M, Miller BL, Cummings JL.

Alzheimers Dement. 2013 Mar;9(2):189-98. doi: 10.1016/j.jalz.2012.03.003. Epub 2012 Oct 10. Review.

PMID:
23062850
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Progress in frontotemporal dementia research.

Wang X, Shen Y, Chen W.

Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):15-23. doi: 10.1177/1533317512467681. Epub 2012 Dec 7. Review.

PMID:
23221030
[PubMed - indexed for MEDLINE]
10.

Frontotemporal dementia: therapeutic interventions.

Mendez MF.

Front Neurol Neurosci. 2009;24:168-78. doi: 10.1159/000197896. Epub 2009 Jan 26. Review.

PMID:
19182475
[PubMed - indexed for MEDLINE]
11.

[Treatment of frontotemporal dementia].

Lebert F.

Psychol Neuropsychiatr Vieil. 2004 Mar;2(1):35-42. Review. French.

PMID:
15683967
[PubMed - indexed for MEDLINE]
12.

[Pharmacological treatment options in frontotemporal dementia].

Kessler H, Supprian T, Falkai P.

Fortschr Neurol Psychiatr. 2007 Dec;75(12):714-9. Epub 2006 Sep 14. Review. German.

PMID:
16972210
[PubMed - indexed for MEDLINE]
13.

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.

van Swieten JC, Heutink P.

Lancet Neurol. 2008 Oct;7(10):965-74. doi: 10.1016/S1474-4422(08)70194-7. Epub 2008 Sep 2. Review.

PMID:
18771956
[PubMed - indexed for MEDLINE]
14.

[Clinical aspects of frontotemporal dementia].

Greck J, Lautenschlager N, Kurz A.

Fortschr Neurol Psychiatr. 2000 Oct;68(10):447-57. Review. German.

PMID:
11103681
[PubMed - indexed for MEDLINE]
15.

Diagnosis and management of behavioral issues in frontotemporal dementia.

Manoochehri M, Huey ED.

Curr Neurol Neurosci Rep. 2012 Oct;12(5):528-36. doi: 10.1007/s11910-012-0302-7. Review.

PMID:
22847063
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

[Frontotemporal dementias].

Witt K, Deuschl G, Bartsch T.

Nervenarzt. 2013 Jan;84(1):20-32. doi: 10.1007/s00115-012-3477-x. Review. German.

PMID:
22366755
[PubMed - indexed for MEDLINE]
17.

Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development.

Boxer AL, Gold M, Huey E, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian Z, Sutherland M, Farese R, Miller BL, Cummings J.

Alzheimers Dement. 2013 Mar;9(2):176-88. doi: 10.1016/j.jalz.2012.03.002. Epub 2012 Oct 5. Review.

PMID:
23043900
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Frontotemporal dementia: genetics and genetic counseling dilemmas.

Goldman JS, Farmer JM, Van Deerlin VM, Wilhelmsen KC, Miller BL, Grossman M.

Neurologist. 2004 Sep;10(5):227-34. Review.

PMID:
15335440
[PubMed - indexed for MEDLINE]
19.

[Diagnosing frontotemporal dementia, a chameleon in psychiatry].

Vleugel EE, Chong YK, van der Mast RC.

Tijdschr Psychiatr. 2006;48(9):705-15. Review. Dutch.

PMID:
17007476
[PubMed - indexed for MEDLINE]
Free Article
20.

From FUS to Fibs: what's new in frontotemporal dementia?

Burrell JR, Hodges JR.

J Alzheimers Dis. 2010;21(2):349-60. doi: 10.3233/JAD-2010-091513. Review.

PMID:
20413882
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk